Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 7/20 | 1.00 |
| ▸ | DPP4 | P27487 | 7/20 | 0.69 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.56 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | CASP1 | P29466 | 3/20 | 0.53 |
| ▸ | CASP7 | P55210 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PTPRC | P08575 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13171786 | 0.83 | ANPEP (0.71) | ANPEPDPP4NR1H2NR1H3NPC1 | |
| SCHEMBL29366407 | 0.82 | DPP4 (0.78) | ANPEPDPP4NR1H2NR1H3TSHR | |
| SCHEMBL2820118 | 0.82 | DPP4 (0.78) | ANPEPDPP4NR1H2NR1H3TSHR | |
| SCHEMBL9812636 | 0.82 | ANPEP (0.69) | ANPEPDPP4NR1H2NR1H3 | |
| SCHEMBL173289 | 0.82 | ANPEP (1.00) | ANPEPDPP4NR1H2NR1H3 | |
| SCHEMBL29566034 | 0.81 | ANPEP (0.68) | ANPEPDPP4NR1H2NR1H3 | |
| SCHEMBL17531021 | 0.80 | ANPEP (0.67) | ANPEPDPP4NR1H2NR1H3NPC1 | |
| SCHEMBL30954668 | 0.80 | ANPEP (0.67) | ANPEPDPP4NR1H2NR1H3NPC1 | |
| SCHEMBL4151437 | 0.80 | ANPEP (1.00) | ANPEPDPP4NPC1ALDH1A1RAB9A | |
| SCHEMBL6925321 | 0.80 | ANPEP (0.66) | ANPEPDPP4NR1H2NR1H3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4024128-B1 | ELECTRONIC DEVICE AND ACCESSORY | CANON KK (JP) | 2026-05-20 | — | — | EP | claimed |
| CN-117415268-B | Method for preparing high-toughness TC11 titanium alloy thick forging plate based on quasi-beta forging | 西部超导材料科技股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4080871-B1 | ELECTRONIC APPARATUS AND ITS CONTROL METHOD, AND ACCESSORY AND ITS CONTROL METHOD | CANON KK (JP) | 2026-03-25 | — | — | EP | claimed |
| CN-121575269-A | TC11 titanium alloy manufactured by high-temperature high-strength high-plasticity LMD additive and preparation method thereof | 海南大学 | 2026-02-27 | — | — | CN | claimed |
| EP-4134739-B1 | ELECTRONIC DEVICE, AND ACCESSORY | CANON KK (JP) | 2026-02-11 | — | — | EP | claimed |
| CN-120193191-A | Preparation method of high-strength and high-toughness titanium alloy framework reinforced magnesium-based composite material | 广东省科学院新材料研究所 | 2025-06-24 | — | — | CN | claimed |
| CN-117070086-B | Protective heat-insulating paint capable of being coated on red and hot metal and application thereof | 北京天力创玻璃科技开发有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-120133691-A | Back pipe welding method for rotary target material | 先导薄膜材料(安徽)有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-120079720-A | Technological method for preparing TC11 high-strength titanium alloy seamless pipe | 西部金属材料股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-115327332-B | Test system and test method for power semiconductor device | 青岛海宜丰电力电子有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-114310183-A | Processing method of axial extrusion type pipe joint | 沈阳航空航天大学 | 2022-04-12 | — | — | CN | claimed |
| CN-112756769-B | Titanium alloy friction welding joint optimization method based on thermal coupling condition | 西安理工大学 | 2022-04-12 | — | — | CN | claimed |
| CN-113481448-B | Titanium alloy member and heat treatment method for titanium alloy member | 北京航空航天大学 | 2022-03-08 | — | — | CN | claimed |
| CN-112097818-B | Bionic impact-resistant sensor packaging structure and manufacturing method thereof | 中北大学 | 2022-03-08 | — | — | CN | claimed |
| CN-114115261-A | Time-adjustable robot tracking sliding mode control method | 集美大学 | 2022-03-01 | — | — | CN | claimed |
| CN-113074126-B | Two-stage axial flow compressor | 上海尚实能源科技有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-114042917-A | Preparation method of micron-sized titanium alloy product | 湖南英捷高科技有限责任公司 | 2022-02-15 | — | — | CN | claimed |
| CN-114029489-A | Method for improving plasticity of powder metallurgy titanium alloy | 湖南英捷高科技有限责任公司 | 2022-02-11 | — | — | CN | claimed |
| WO-2008154353-A1 | THALIDOMIDE ANALOGS FOR TREATING VASCULAR ABNORMALITIES | CHARLESSON, LLC (US) | 2008-12-18 | — | — | WO | claimed |
| US-20080306134-A1 | THALIDOMIDE ANALOGS FOR TREATING VASCULAR ABNORMALITIES | CHARLESSON, LLC | 2008-12-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306134-A1 | THALIDOMIDE ANALOGS FOR TREATING VASCULAR ABNORMALITIES | VEGFA, FLT1, VCAM1 | ANPEP 3507/4885DPP4 4355/4885NR1H2 4128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.